Cowen And Company, LLC Innoviva, Inc. Call Options Transaction History

Cowen And Company, LLC

  • $3.88 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 08, 2021
SELL
$9.33 - $12.48 $2.18 Million - $2.92 Million
-234,100 Closed
0 $0
Q3 2020

Nov 03, 2020
SELL
$10.33 - $14.49 $8.28 Million - $11.6 Million
-801,800 Reduced 77.4%
234,100 $53,000
Q2 2020

Aug 13, 2020
BUY
$11.49 - $15.26 $11.9 Million - $15.8 Million
1,035,900 New
1,035,900 $4.45 Million

Others Institutions Holding INVA

# of Institutions
228
Shares Held
79.1M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.32B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email